Publications

Use of measles supplemental immunization activities (SIAs) as a delivery platform for other maternal and child health interventions: opportunities and challenges.

Johri, M; Sharma, JK; JIT, M; Verguet, S;

2013

Vaccine, (2013).31 9 10.1016/j.vaccine.2012.09.044.

Uptake of neonatal BCG vaccination in England: performance of the current policy recommendations.

NGUIPDOP-DJOMO, P; MANGTANI, P; PEDRAZZOLI, D; RODRIGUES, LC; Abubakar, I;

2013

Thorax, (2013).69 1 10.1136/thoraxjnl-2013-203931.

Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens.

WHITE, MJ; Nielsen, CM; McGregor, RH C; RILEY, EH C; GOODIER, MR;

2013

Immunology, (2013).142 1 10.1111/imm.12239.

Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials.

MANGTANI, P; Abubakar, I; ARITI, C; Beynon, R; Pimpin, L; FINE, PE M; RODRIGUES, LC; SMITH, PG; Lipman, M; Whiting, PF; Sterne, JA;

2013

Clinical infectious diseases, (2013).58 4 10.1093/cid/cit790.

Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience.

Toscano, CM; Jauregui, B; Janusz, CB; Sinha, A; CLARK, AD; SANDERSON, C; Resch, S; Ruiz Matus, C; Andrus, JK; ProVac Network of Centers of Excellence,;

2013

Vaccine, (2013).31 Sup SUPPL. 10.1016/j.vaccine.2013.05.033.

Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England.

Mesher, D; Soldan, K; Howell-Jones, R; Panwar, K; Manyenga, P; JIT, M; Beddows, S; Gill, ON;

2013

Vaccine, (2013).32 1 10.1016/j.vaccine.2013.10.085.

The effect of perceived risks on the demand for vaccination: results from a discrete choice experiment.

Sadique, MZ; Devlin, N; EDMUNDS, WJ; Parkin, D;

2013

PloS one, (2013).8 2 10.1371/journal.pone.0054149.

TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.

CLARK, A; Jauregui, B; GRIFFITHS, U; Janusz, CB; Bolaños-Sierra, B; Hajjeh, R; Andrus, JK; SANDERSON, C;

2013

Vaccine, (2013).31 Sup SUPPL. 10.1016/j.vaccine.2013.05.045.

Acceptability and uptake of female adolescent HPV vaccination in Hong Kong: a survey of mothers and adolescents.

Choi, HC W; Leung, GM; Woo, PP S; JIT, M; Wu, JT;

2013

Vaccine, (2013).32 1 10.1016/j.vaccine.2013.10.068.

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts.

JIT, M; Levin, C; Brisson, M; Levin, A; Resch, S; Berkhof, J; Kim, J; Hutubessy, R;

2013

BMC medicine, (2013).11 1 10.1186/1741-7015-11-23.